(PUB) Investing 2016
7
April 2016
Morningstar FundInvestor
Data through March 31, 2016 FINRA members: For internal or institutional use only. Sequoia
Ticker SEQUX
Yield 0.0%
Total Assets $5,470 mil
Mstar Category Large Growth
Benchmark 1: Russell 1000 Growth TR USD Benchmark 2: S&P 500 TR USD Morningstar Analyst Rating 03-24-16 ´
Investment Style Equity
Historical Profile Return Risk Rating Below Avg Below Avg QQ Below Avg
7 7 7 7 7 7 7 7
20.0 25.0
Growth of $10,000
Investment Values of Fund Investment Values of Benchmark 1
15.0
Morningstar Pillars Process
∞ Positive ¶ Neutral ∞ Positive ∞ Positive ¶ Neutral
10.0
Performance
People Parent
Performance Quartile (within Category)
) & & ) & & * * ) ) ) 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 03-16 152.75 139.12 95.27 109.90 129.29 145.50 168.31 222.92 235.00 207.26 183.85 8.34 8.40 -27.03 15.38 19.50 13.19 15.68 34.58 7.55 -7.29 -11.30 -0.73 -3.41 11.41 -21.83 2.78 10.55 0.42 1.09 -5.50 -12.96 -12.04 -7.45 2.91 9.97 -11.08 4.43 11.08 -0.33 2.19 -6.14 -8.68 -12.64 0.00 0.31 0.31 0.02 0.29 0.00 0.00 0.00 0.00 0.00 0.00 8.34 8.10 -27.33 15.36 19.21 13.19 15.68 34.58 7.55 -7.29 -11.30 0.00 0.45 0.42 0.02 0.31 0.00 0.00 0.00 0.00 0.00 0.00 15.60 27.12 6.72 0.00 1.65 0.82 0.00 3.40 4.54 10.51 0.00 1.00 1.00 1.00 1.05 1.04 1.03 1.03 1.02 1.03 1.03 . -0.50 0.30 0.30 0.01 0.00 -0.34 -0.26 -0.37 -0.26 -0.42 . 97 25 3 97 7 1 42 42 78 98 99
Price
History
Morningstar Analyst Rating Morningstar evaluates mutual funds based on five key pillars, which its analysts believe lead to funds that are more likely to outperform over the long term on a risk-adjusted basis. Analyst Rating Spectrum Œ „ ´ ‰ Á
NAV
Total Return % +/- Bmark 1 +/- Bmark 2 Income Return % Capital Return % Capital Gains $ Expense Ratio % Income Ratio % Turnover Rate % Net Assets $mil Total Rtn % Rank Cat Income $
Pillar Spectrum ∞ Positive
§ Negative
¶ Neutral
Performance 03-31-16 1st Qtr 2nd Qtr
3rd Qtr
4th Qtr
Total
2012 2013 2014 2015 2016
10.76 -4.95 6.48 3.20 15.68 10.77 3.50 7.60 9.09 34.58 1.78 -0.86 -0.65 7.28 7.55 7.67 1.98 -7.12 -9.09 -7.29
.
14
13
12
15
23
3
5
2
8
10
3,600 3,513 2,486 2,868 3,511 4,895 5,828 8,037 8,070 6,744 5,470
Rating and Risk Time Period Load-Adj Return %
Portfolio Analysis 12-31-15 Total Stocks: 39 Share change since 09-30-15
-11.29
— — — —
Morningstar Rtn vs Cat
Morningstar Risk vs Cat
Morningstar Risk-Adj Rating
Sector
YTD Ret % % Assets — 19.31 7.91 8.33 10.79 6.92 7.99 6.20 20.77 5.28 7.45 4.92 -2.74 4.30 — 4.13 7.41 3.40 0.80 3.21 — 2.61 — 2.35 — 2.03 -1.94 1.86 — 1.82 -1.98 1.67 3.81 1.38 — 1.29 2.30 1.05 10.67 1.04
Trailing
Total Return%
+/- Bmark 1
+/- Bmark 2
%Rank Cat
Growth of $10,000
T Valeant Pharmaceuticals I Berkshire Hathaway Inc A
Hlth Care Finan Svcs Cnsmr Cyc Cnsmr Cyc
1 Yr 3 Yr 5 Yr
-23.62
3 Mo 6 Mo
-11.30 -12.04 -12.64 -19.36 -27.47 -27.84 -23.62 -26.14 -25.41 2.43 -11.18 -9.39 7.13 -5.25 -4.45 6.02 -2.26 -0.99 6.92 0.89 0.03
99 8,871 100 8,064 100 7,638 99 10,746 91 14,111 69 17,941 11 27,287
Low +Avg Q
2.43 7.13 6.02
TJX Companies Inc
-Avg QQ Low QQQ
-Avg
1 Yr
O'Reilly Automotive Inc
10 Yr Incept
Avg
3 Yr Avg 5 Yr Avg 10 Yr Avg 15 Yr Avg
Fastenal Co
Industrl
13.61
Berkshire Hathaway Inc B
Finan Svcs Finan Svcs
MasterCard Inc A
Other Measures
Standard Index
Best Fit Index
Precision Castparts Corp IDEXX Laboratories Inc Mohawk Industries Inc Constellation Software In Rolls-Royce Holdings PLC Sirona Dental Systems Inc
Industrl
Alpha
-2.1 0.45
-5.6 0.56
Hlth Care Cnsmr Cyc Technology
Beta
Tax Analysis
Tax Adj Rtn% %Rank Cat Tax-Cost Rat %Rank Cat
R-Squared
14
30
3 Yr (estimated) 5 Yr (estimated) 10 Yr (estimated)
1.74 6.68 5.24
98 74 62
0.67 0.42 0.73
16 13 39
Standard Deviation
13.46
Industrl
Mean
2.43 0.24
Hlth Care
Sharpe Ratio
Alphabet Inc A Alphabet Inc C Waters Corp
Technology Technology
Potential Capital Gain Exposure: 55% of assets
Morningstar's Take by Kevin McDevitt, CFA 03-24-16 Sequoia's Morningstar Analyst Rating has been changed to Bronze following manager Bob Goldfarb's resignation and given revisions to the fund's process. Manager David Poppe and his team remain, however, and have the experience and skill to get the fund back on track. Goldfarb stepped down as comanager of this fund on March 23, 2016, following the implosion of the Valeant Pharmaceuticals VRX stake. This was a mutual decision, but the fund's board and others at the firm felt that decision-making had become too centralized and others on the team needed to have more input. Although this isn't how the firm envisioned this transition, it has been preparing for it for years, having added six analysts to the 12-person team during the past decade. Going forward, the team plans to introduce new risk controls to avoid future blowups. Poppe will establish an investment committee with himself and three senior analysts. The plan is to make the process more collaborative, as well as to introduce checks and balances. For example, the other three members of the investment committee could override Poppe on a buy/sell decision.
Hlth Care
Jacobs Engineering Group Miscellaneous Securities
Industrl
While the damage has been done, Valeant no longer dominates the portfolio. The fund sold 1.5 million shares in mid-March to raise cash and book capital losses. That, coupled with Valeant's nearly 70% year-to-date decline, means the position is now likely less than 7% of assets. The sale left the fund with $800 million in cash, or about 14.5% of assets. This gives the fund a bit of a buffer as it likely continues to deal with outflows, which were an estimated $300 million over the three months through February. Despite the Valeant disaster, this fund still has real strengths.Poppe isanexperienced investorwith talented analysts supporting him. However, even though they plan to stick with the firm's classic approach, their increased emphasis on risk control will change the fund's character. Although concentration brought risks, it was also a key to the fund's strong returns. How efforts to reduce risk will affect returns is an open question for now.
—
Danaher Corp
Industrl
Omnicom Group Inc
Cnsmr Cyc
Current Investment Style
Sector Weightings h Cyclical r BasicMat t CnsmrCyc y FinanSvcs u Real Est j Sensitive i CommSrvs o Energy p Industrl a Technlgy k Defensive s CnsmrDef d Hlthcare f Utilities
% of Stocks
Rel Bmark 1
Market Cap % Giant 45.6 Large 29.2 Mid 23.6 Small 1.6 Micro 0.0 Avg $mil: 35,531
Value Blend Growth
Large Mid Small
44.01 1.49 2.22 0.71 21.76 1.14 20.03 3.90 0.00 0.00 25.00 0.58 0.00 0.00 0.06 0.12 16.68 1.31 8.26 0.34 30.99 1.12 0.98 0.09 30.01 1.84 0.00 0.00
Value Measures
Rel Category
Price/Earnings 19.88
0.95 0.92 0.91 1.06 0.57 0.96 1.24 1.39 1.62 0.87
Price/Book Price/Sales
3.28 2.06
Price/Cash Flow 13.35 Dividend Yield % 0.75
Growth Measures
% Rel Category
Long-Term Erngs 12.00
Book Value
11.04 11.22
Composition - Net
Sales
Cash 5.2 Stocks 93.9 Bonds 0.9 Other 0.0 Foreign 29.8 (% of Stock)
Address:
Sequoia Fund Inc
Minimum Purchase: Min Auto Inv Plan:
$5000 $5000
Add: — IRA: $2500
Cash Flow 20.55 Historical Erngs 10.83
New York, NY 10153-4798
Add: —
800-686-6884
Sales Fees:
No-load
Web Address:
www.sequoiafund.com
Management Fee:
1.00%
Profitability
%
Inception:
07-15-70
Actual Fees:
Mgt:1.00% Dist:—
Return on Equity Return on Assets
24.68
Advisor:
—
Expense Projections: Income Distribution:
3Yr:$328 5Yr:$569 10Yr:$1259
8.92
Subadvisor:
None
Annually
Net Margin
11.36
A
ß ® Mutual Funds
©2016Morningstar, Inc.All rights reserved. The information herein is not represented orwarranted to be accurate, complete or timely. Past performance is no guarantee of future results.Access updated reports at www.morningstar.com . To order reprints, email reprints@morningstar.com
Made with FlippingBook